SUBSCRIBE
SUBSCRIBE

Cancer Stem Cell Therapeutics Market Size up to 2030 - Quantitative Research by QYResearch Medical

November 17, 2022 | 
8 min read

The global Cancer Stem Cell Therapeutics Market was valued at USD 10.15 Billion in 2020 and is expected to reach USD 20.08 Billion by 2030, at a CAGR of 9.0%.

The global Cancer Stem Cell Therapeutics Market was valued at USD 10.15 Billion in 2020 and is expected to reach USD 20.08 Billion by 2030, at a CAGR of 9.0%. Cancer stem cells (CSCs) refer to the cells which are produced from tumour and possess characteristics to foster several types of cancer cells procured in a cancer sample. They are supposed to grow in tumour as separate population and have the capabilities of self-renewal which leads to generation of new tumour. Cancer Stem Cell therapeutics indicated for Blood cancer and plasma cell cancer and other underlying diseases leading to the increase of leukaemia and myeloma. Key recent developments in the field of cancer stem cell pharmaceutical include production of stem cell drugs. For instance, NEUROSTEM and PNEUMOSTEM are the two upcoming drugs by MEDIPOST where PNEUMOSTEM has completed its Phase 2 clinical trial in Korea and its administration in Phase ½ (FDA) clinical trial in U.S. Orphan Drug Designation and NEUROSTEM is going through its Phase ½ a clinical trial of Ministry of Food and Drug Safety and preparing for clinical trial (FDA) in U.S.

Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118306

The factors such as rising public-private investments, growing public recognition about the therapeutic strength of products and developing regulatory framework for stem cell therapeutics are fuelling the growth of the market and restricting the growth of tumours. Due to the increasing rates of morbidity and mortality rate of cancer and immense funding from the Government, many cancer research activities have increased to prevent cancer and treatment of cancer is the topmost priority worldwide. Due to a substantial number of publicized reports on “Cancer Stem Cell (CSC) disorder”, extensive prospective for anti-CSC’s therapeutics have been created and it has improved the basic understanding of the clinical events which is categorised as the main factor for such a rising interest in CSC model. Increasing number of approvals from FDA of stem cell therapy has incremented the demand for CSC therapy production process. The growing widespread of prolonged diseases and large number of stem cell benefactors are the important factors propelling the growth of the market. The restraints that are generally faced by global cancer cell stem market are the operational costs associated with the manufacturing process; rigid guidelines for clinical trials, regulatory challenges related to approvals inhibit the growth of the market.

The cancer stem cell therapeutics market is much fragmented and includes a large number of pharmaceutical giants as well as emerging players. Additionally, the emerging players have a good opportunity to enter the stem cell therapeutics market, owing to availability of research funding and immense government support to combat cancer. For instance, in April 2020, STEMCELL Technologies, Canada’s biggest biotechnology firm accepted USD 45 million from a joint venture of Government of Canada and British Columbia for the expansion of technologies to assist clinical trials in the field of cell therapy, tissue engineering, immunotherapy, gene therapy and reformative medicine to treat cancer and other diseases.

Related Reports:

Key Coverage of the Report:

  • Region and country-wise assessment from the period 2019-2030. For the study, 2016-2017 has been utilized as historical data, 2020 as the base year, and 2019-2030, has been derived as forecasts
  • Regional Competitors clinical pipeline analysis
  • Demand and Supply GAP Analysis
  • Market share analysis of the key industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 6 years of all the mentioned segments, and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments.

Salient Trends of the Global Cancer Stem Cell Therapy Market:

  • In January 2019, a group of investors in founded a new company, i.e., ProKidney by raising USD 75 million, and spent USD 62 million to acquire the cell therapy company inRegen and its manufacturing affiliate, Twin City Bio to develop kidney stem-cell therapies
  • In December 2020, Kineta Immuno-Oncology, LLC (KIO), a subsidiary of Kineta Inc, entered into a research collaboration and license agreement with Pfizer Inc. to develop RIG-I agonist immunotherapies for cancer treatment
  • Launch of new drugs for advanced cancer stem cell treatment supports the market growth during coming years. For instance, in October 2017, Gilead received FDA approval for production of its Yescarta for the treatment of patients who have relapsed large B-cell lymphoma.
  • The Merger and Acquisition (M&A) deal between CSL Behring and Calimmune Inc., took effect on August, 2017 will provide CSL Behring with Calimmune’s pre-clinical asset, CAL-H, an HSC gene therapy for the treatment of sickle cell disease and β-thalassemia, which complements CSL Behring’s current product portfolio and deep expertise in haematology
  • In July 2017, Lonza has acquired Capsugel S.A. to get the best solution to pharma and consumer end-users
  • There are promising drugs for chronic cancer stem cell in the clinical pipeline. The anticipated launch of the drugs is likely to support the market growth during forecast period
  • Technological improvements in stem cell production and continuous rise in the number of research studies on cancer stem cells (CSCs) being published is anticipated to create prospects for the growth of global cancer stem cell therapeutics market.
  • Bone marrow stem cell transplant segment has hold the market at a share of 21.1% in 2020
  • Asia Pacific region has the highest prevalence rate for Cancer. Asia Pacific region is anticipated to hold 12% of market share by year 2030. For instance, Australia has the highest age-standardized incidence rate of multiple myeloma, followed by high-income North America and Western Europe

Companies considered and profiled in this market study:

The Global Cancer Stem Cell Therapy Market study postulates constructive intuition globally which includes the companies who are the key players in Global Cancer Stem Cell Therapy Market, such as AbbVie Inc., Advanced Cell Diagnostics Inc., Athersys Inc., AVIVA Biosciences, Beckton Dickson and Company, Bionomics, Epic Sciences, Immunocellular Therapeutics Ltd, JCR Pharmaceuticals, LONZA Group AG, MEDIPOST, Merck KGA, Novartis, Osiris Therapeutics, Oncomed Pharmaceuticals, Pfizer, Stemline Therapeutics Inc., STEMCELL Technologies, Takara Bio Inc., Thermo Fischer Scientific Inc.

Market-O-Nomics:

  • The allogeneic stem cell transplant therapy is the leading treatment type segment which is expected to grow at a CAGR i.e., 8.9% during the forecast period, owing to its huge development and sales than autologous stem cell therapy and even many cell therapy companies have invested a lot behind the development of allogeneic products
  • The market for breast cancer disease type segment has dominated the market in 2020
  • The pharmaceutical and biotech companies segment accounted for the largest share of the market in 2017 i.e. 59.2%
  • The musculoskeletal disorders segment dominates the market due to large commercialisation of Bone Marrow Stem Cell Transplant
  • North America regional segment of the cancer stem cell therapeutics market is growing at a rate of 8.9%. Increased interest in patients willing to undergo the stem cell treatment

Segments covered in the report:

For the purpose of the study, this report segments the Global Cancer Stem Cell Therapy Market on the basis of product type, treatment type, disease type, application, end user and the regional outlook at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2020 to 2030.

Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118306

Global Cancer Stem Cells Key Market Segments:

Treatment Type: (Revenue, USD Million; 2020–2030)

  • Autologous Stem Cell Transplants
  • Allogeneic Stem Cell Transplants
  • Syngeneic Stem Cell Transplants
  • Bone Marrow Stem Cell Transplants

Disease Type: (Revenue, USD Million; 2020–2030)

  • Breast Cancer
  • Blood Cancer
  • Lung Cancer
  • Brain Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • Bladder Cancer
  • Liver Cancer
  • Others

Application: (Revenue, USD Million; 2020–2030)

  • Musculoskeletal disorders
  • Neurodegenerative disorders
  • Cardiovascular diseases
  • Gastrointestinal diseases
  • Autoimmune Disorders
  • Wounds and injuries
  • Surgeries
  • Malignancies
  • Dermatology

End Use: (Revenue, USD Million; 2020–2030)

  • Hospitals and Surgical Centres
  • Pharmaceutical and Biotech Companies
  • Cell Banks and Tissue Banks
  • Academic Institutes, Research Laboratories, and CROs
  • Others

Regional Outlook: (Revenue, USD Million; 2020–2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
    • GCC
    • Turkey
    • Egypt
  • South Africa

Buy quantitative research Report at discounted price - USD 1500 https://qyresearchmedical.com/report/checkout/118306/1500

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

About Us

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.

For Latest Update Follow Us:

URL - http://www.qyresearchmedical.com/

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Precedence Research